Related references
Note: Only part of the references are listed.Trials that say maybe: the disconnect between exploratory and confirmatory testing after drug approval
Benjamin Carlisle et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries
Camille Ponte et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Prescription Medication Use Among Community-Based US Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study
Anna Shmagel et al.
JOURNAL OF PAIN (2018)
Trials that say maybe: the disconnect between exploratory and confirmatory testing after drug approval
Benjamin Carlisle et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study
Anne Benard-Laribiere et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings
Mance E. Buttram et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study
Tara Gomes et al.
PLOS MEDICINE (2017)
Gabapentin and pregabalin: do the benefits outweigh the harms?
E. E. Morrison et al.
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Risk to heroin users of polydrug use of pregabalin or gabapentin
Abigail Lyndon et al.
ADDICTION (2017)
Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study
Tove Abrahamsson et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Abuse and Misuse of Pregabalin and Gabapentin
Kirk E. Evoy et al.
DRUGS (2017)
Misuse of gabapentin and pregabalin: a marker for a more serious malaise?
Cathy Stannard
ADDICTION (2016)
Gabapentin misuse, abuse and diversion: a systematic review
Rachel V. Smith et al.
ADDICTION (2016)
Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database
Jean-Baptiste Bossard et al.
CLINICAL DRUG INVESTIGATION (2016)
Abuse Potential of Pregabalin
Ole Schjerning et al.
CNS DRUGS (2016)
A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database
Stefania Chiappini et al.
CNS DRUGS (2016)
Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies
Aurore Palmaro et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2016)
Use of Pregabalin - A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential
O. Schjerning et al.
PHARMACOPSYCHIATRY (2016)
Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history
Damien Driot et al.
THERAPIE (2016)
Abuse of Gabapentin is Associated with Opioid Addiction
Leo Bastiaens et al.
PSYCHIATRIC QUARTERLY (2016)
The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study
Ingeborg Rossow et al.
BMC PUBLIC HEALTH (2015)
Benzodiazepines and risk of death: Results from two large cohort studies in France and UK
Aurore Palmaro et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
French health insurance databases: What interest for medical research
G. Moulis et al.
REVUE DE MEDECINE INTERNE (2015)
Drug Abuse Monitoring: Which Pharmacoepidemiological Resources at the European Level?
Maryse Lapeyre-Mestre et al.
THERAPIE (2015)
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
Eric I. Benchimol et al.
PLOS MEDICINE (2015)
Prescription Medication Misuse Among Opioid Dependent Patients Seeking Inpatient Detoxification
Timothy Wilens et al.
AMERICAN JOURNAL ON ADDICTIONS (2015)
Potentiation of the Effect of Buprenorphine/Naloxone With Gabapentin or Quetiapine
Roy R. Reeves et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK
Vikas Kapil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?
Fabrizio Schifano
CNS DRUGS (2014)
Factors associated with pregabalin dispensing at higher than the approved maximum dose
Robert Boden et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Gabapentinoid Abuse in Order to Potentiate the Effect of Methadone: A Survey among Substance Misusers
Colin R. W. Baird et al.
EUROPEAN ADDICTION RESEARCH (2014)
Adverse Drug Reactions to Gabapentin and Pregabalin A Review of the French Pharmacovigilance Database
Regis Fuzier et al.
DRUG SAFETY (2013)
Pregabalin abuse among opiate addicted patients
Martin Grosshans et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Concerns About Pregabalin: Further Experience With Its Potential of Causing Addictive Behaviors
Maximilian Gahr et al.
JOURNAL OF ADDICTION MEDICINE (2013)
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations
Shannon M. Smith et al.
PAIN (2013)
Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011
Lise Aagaard et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
Substance misuse of gabapentin
Blair H. Smith et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2012)
Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France
V. Pauly et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey
Elisabeth Frauger et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2012)
The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials
Gaetano Zaccara et al.
EPILEPSIA (2011)
Earlier discovery of pregabalin's dependence potential might have been possible
Ola Caster et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network
Elisabeth Frauger et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2011)
Is There a Recreational Misuse Potential for Pregabalin? Analysis of Anecdotal Online Reports in Comparison with Related Gabapentin and Clonazepam Data
Fabrizio Schifano et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2011)
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial
Giovanni Martinotti et al.
ADDICTION (2010)
Assessment of Abuse Potential of Benzodiazepines from a Prescription Database Using 'Doctor Shopping' as an Indicator
Vincent Pradel et al.
CNS DRUGS (2010)
Pregabalin in the Treatment of Alcohol and Benzodiazepines Dependence
Panagiotis Oulis et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system
Sofie Schwan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
French national health insurance information system and the permanent beneficiaries sample
P. Tuppin et al.
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2010)
Share Paper
